German CRO harmonizes patient health data from
multiple sources to boost clinical study efficiency
BARCELONA, Spain, Sept. 21, 2023 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that palleos healthcare has
selected Veeva Vault Clinical Data Management Suite (CDMS)
with Veeva Vault EDC and Veeva CDB (clinical database) to connect
all clinical study data on one platform. A unified view of clinical
data from wearables and other sources offers palleos healthcare
greater visibility and control to adapt studies in real time.
"Managing high volumes of data from multiple sources, including
wearables that monitor patient health status, is a demanding task,"
said Dr. Philip Raeth, managing
director at palleos healthcare. "Unifying data with Veeva Vault EDC
and Veeva CDB gives palleos healthcare real-time insight into how a
study is progressing, enabling us to better assess and manage
outcomes."
Based in Germany, palleos
healthcare is an international end-to-end full-service contract
research organization (CRO) with sponsor capabilities in clinical
studies covering phase I-IV drug and medical device trials for
various indications, as well as (pre)-clinical consulting services.
Using Vault EDC, palleos healthcare can easily design
specifications, execute studies, and accommodate mid-study changes
with zero downtime. Veeva CDB brings together palleos healthcare's
study data from multiple sources into one cohesive data format to
make data cleaning, reporting, and export more efficient.
"palleos healthcare is forward thinking in its management of
increasingly complex clinical trials," said Paul MacDonald, senior director of strategy for
Vault CDMS. "Veeva Vault EDC and Veeva CDB offer palleos healthcare
a comprehensive view of their study data, enabling them to further
advance clinical trial execution to benefit patients."
Vault CDMS is part of Veeva Development Cloud, the operating
system for product development that brings together applications
for clinical, quality, regulatory, and safety to help organizations
drive end-to-end business processes.
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and
services and the expected results or benefits from use of
our products and services. These statements are based on
our current expectations. Actual results could differ
materially from those provided in this release and we have no
obligation to update such statements. There are numerous
risks that have the potential to negatively impact
our results, including the risks and uncertainties disclosed
in our filing on Form 10-Q for the period ended July 31, 2023, which you can
find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Heiko Bergmann
palleos healthcare GmbH
+49-611-950-190-0 ext. 50
heiko.bergmann@palleos.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/palleos-healthcare-advances-clinical-trial-execution-with-veeva-vault-clinical-data-applications-301933218.html